The busiest two weeks of first quarter earnings season are over. Here are the most significant reports.
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript May 2, 2024 TG Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the TG Therapeutics Conference Call and Webcast. At this time all participants are […]
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls